Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation

• Main Authors: Di Wu (Author), Jianxiang Xie (Author), Huizhen Dai (Author), Wentong Fang (Author)
• Format: Book
• Published: BMC, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used in the treatment of EGFR mutation non-small-cell lung cancer. The Chinese government has made great efforts to improve the availability and affordability of these drugs. The aim of thi...